Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States.
- DOI
- 10.1016/j.urolonc.2026.06.017
- Published
- 2026 Sep
- Container
- Urologic oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.urolonc.2026.06.017,
title = {Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States.},
author = {George DJ and Kariburyo-Yay F and Aggarwal H and Tepsick JG and Yu R and Li W and Orji C and Ghate SR},
year = {2026},
journal = {Urologic oncology},
doi = {10.1016/j.urolonc.2026.06.017},
url = {https://doi.org/10.1016/j.urolonc.2026.06.017}
}RIS
TY - JOUR TI - Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States. AU - George DJ AU - Kariburyo-Yay F AU - Aggarwal H AU - Tepsick JG AU - Yu R AU - Li W AU - Orji C AU - Ghate SR PY - 2026 JO - Urologic oncology DO - 10.1016/j.urolonc.2026.06.017 UR - https://doi.org/10.1016/j.urolonc.2026.06.017 ER -
APA
DJ, G., F, K., H, A., JG, T., R, Y., W, L., C, O., & SR, G. (2026). Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2026.06.017
Source records
- pubmed · retrieved 2026-09-25T12:31:03.949Z